149 related articles for article (PubMed ID: 18752263)
1. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.
Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML
J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263
[TBL] [Abstract][Full Text] [Related]
2. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats.
Xiong MP; Yáñez JA; Remsberg CM; Ohgami Y; Kwon GS; Davies NM; Forrest ML
J Control Release; 2008 Jul; 129(1):33-40. PubMed ID: 18456363
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
5. Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat.
Binkhathlan Z; Hamdy DA; Brocks DR; Lavasanifar A
Eur J Pharm Biopharm; 2010 Jun; 75(2):90-5. PubMed ID: 20332028
[TBL] [Abstract][Full Text] [Related]
6. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.
Katragadda U; Fan W; Wang Y; Teng Q; Tan C
PLoS One; 2013; 8(3):e58619. PubMed ID: 23505544
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
8. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
Forrest ML; Yáñez JA; Remsberg CM; Ohgami Y; Kwon GS; Davies NM
Pharm Res; 2008 Jan; 25(1):194-206. PubMed ID: 17912488
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles as a novel formulation approach for tanespimycin (17-AAG) against leishmania infections: Preparation, characterization and macrophage uptake.
Pires VC; Magalhães CP; Ferrante M; Rebouças JS; Nguewa P; Severino P; Barral A; Veras PST; Formiga FR
Acta Trop; 2020 Nov; 211():105595. PubMed ID: 32585150
[TBL] [Abstract][Full Text] [Related]
11. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
Shin DH; Kwon GS
Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
[TBL] [Abstract][Full Text] [Related]
12. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
Cho H; Kwon GS
J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.
Larson N; Greish K; Bauer H; Maeda H; Ghandehari H
Int J Pharm; 2011 Nov; 420(1):111-7. PubMed ID: 21856392
[TBL] [Abstract][Full Text] [Related]
16. Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles.
Han Y; He Z; Schulz A; Bronich TK; Jordan R; Luxenhofer R; Kabanov AV
Mol Pharm; 2012 Aug; 9(8):2302-13. PubMed ID: 22681126
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed,
Petersen ALOA; Campos TA; Dantas DADS; Rebouças JS; da Silva JC; de Menezes JPB; Formiga FR; de Melo JV; Machado G; Veras PST
Front Cell Infect Microbiol; 2018; 8():303. PubMed ID: 30214897
[TBL] [Abstract][Full Text] [Related]
18. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.
Yáñez JA; Forrest ML; Ohgami Y; Kwon GS; Davies NM
Cancer Chemother Pharmacol; 2008 Jan; 61(1):133-44. PubMed ID: 17393166
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug delivery to tumor cells via micellar nanocarriers.
Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
[TBL] [Abstract][Full Text] [Related]
20. Ionically fixed polymeric nanoparticles as a novel drug carrier.
Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
